1. Home
  2. VSH vs GLPG Comparison

VSH vs GLPG Comparison

Compare VSH & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • GLPG
  • Stock Information
  • Founded
  • VSH 1962
  • GLPG 1999
  • Country
  • VSH United States
  • GLPG Belgium
  • Employees
  • VSH N/A
  • GLPG N/A
  • Industry
  • VSH Electrical Products
  • GLPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • GLPG Health Care
  • Exchange
  • VSH Nasdaq
  • GLPG Nasdaq
  • Market Cap
  • VSH 1.8B
  • GLPG 1.8B
  • IPO Year
  • VSH N/A
  • GLPG 2005
  • Fundamental
  • Price
  • VSH $13.15
  • GLPG $25.32
  • Analyst Decision
  • VSH Hold
  • GLPG Sell
  • Analyst Count
  • VSH 2
  • GLPG 4
  • Target Price
  • VSH $20.50
  • GLPG $25.33
  • AVG Volume (30 Days)
  • VSH 2.1M
  • GLPG 466.6K
  • Earning Date
  • VSH 05-07-2025
  • GLPG 04-23-2025
  • Dividend Yield
  • VSH 3.05%
  • GLPG N/A
  • EPS Growth
  • VSH N/A
  • GLPG N/A
  • EPS
  • VSH N/A
  • GLPG N/A
  • Revenue
  • VSH $2,906,544,000.00
  • GLPG $311,493,731.00
  • Revenue This Year
  • VSH $4.78
  • GLPG N/A
  • Revenue Next Year
  • VSH $8.38
  • GLPG N/A
  • P/E Ratio
  • VSH N/A
  • GLPG N/A
  • Revenue Growth
  • VSH N/A
  • GLPG 18.32
  • 52 Week Low
  • VSH $10.35
  • GLPG $22.36
  • 52 Week High
  • VSH $24.69
  • GLPG $31.23
  • Technical
  • Relative Strength Index (RSI)
  • VSH 49.56
  • GLPG 45.40
  • Support Level
  • VSH $12.00
  • GLPG $25.20
  • Resistance Level
  • VSH $13.92
  • GLPG $27.64
  • Average True Range (ATR)
  • VSH 0.57
  • GLPG 0.59
  • MACD
  • VSH 0.22
  • GLPG -0.09
  • Stochastic Oscillator
  • VSH 74.55
  • GLPG 23.93

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Share on Social Networks: